Fasenra Pediatric Japan Post-Marketing Study(PMS)

Trial Identifier: D3250C00100
Sponsor: AstraZeneca
Start Date: July 2024
Primary Completion Date: March 2027
Study Completion Date: March 2027
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

No locations posted.